Founded in 2015, Centus Biotherapeutics is a joint venture between AstraZeneca, a global pharmaceutical leader, and Fujifilm Kyowa Kirin Biologics (FKB), a Japanese biopharmaceutical company focused on biosimilar development. With the unique coupling of world class biologics expertise, global commercial infrastructure and deep biosimilar development experience, Centus Biotherapeutics is well positioned to win the trust of doct...
Founded in 2015, Centus Biotherapeutics is a joint venture between AstraZeneca, a global pharmaceutical leader, and Fujifilm Kyowa Kirin Biologics (FKB), a Japanese biopharmaceutical company focused on biosimilar development. With the unique coupling of world class biologics expertise, global commercial infrastructure and deep biosimilar development experience, Centus Biotherapeutics is well positioned to win the trust of doctors and serve the needs of patients worldwide.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.